Ezlopitant metabolite M17

N-(5-methyl-1,2-oxazol-3-yl)-2-[(1,3,9-trimethyl-2,6-dioxo-5H-purin-9-ium-8-yl)sulfanyl]acetamide

N-(1,3-benzothiazol-2-yl)-2-[(1,3,9-trimethyl-2,6-dioxo-5H-purin-9-ium-8-yl)sulfanyl]acetamide

N-(3,5-dimethoxyphenyl)-2-[(1,3,9-trimethyl-2,6-dioxo-5H-purin-9-ium-8-yl)sulfanyl]acetamide

N-(5-chloro-2-methoxyphenyl)-2-[(1,3,9-trimethyl-2,6-dioxo-5H-purin-9-ium-8-yl)sulfanyl]acetamide

5-[5-(3,4-dichlorophenyl)furan-2-yl]-8,8-dimethyl-2-sulfanylidene-4a,5,7,9,10,10a-hexahydro-1H-pyrimido[4,5-b]quinoline-4,6-dione

N-(5-acetamido-2-methoxyphenyl)-2-(4-oxo-1H-phthalazin-1-yl)acetamide

1-(3-methoxy-4-pentoxyphenyl)-2-(oxolan-2-ylmethyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione

7-[(4-bromophenyl)methyl]-8-[(2,6-dimethylmorpholin-4-yl)methyl]-1,3-dimethyl-5H-purin-7-ium-2,6-dione

4,7,8-trimethyl-6-(2-methylpropyl)-2-(2-piperidin-1-ylethyl)-9aH-purino[7,8-a]imidazol-6-ium-1,3-dione

6,7-dimethyl-2-pyridin-2-yl-1-(3,4,5-trimethoxyphenyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione